The brain fog piece of perimenopause is the one that scares women the most — and it's the one that sends them deepest into supplement rabbit holes. When lion's mane started showing up everywhere, it felt like finally, something real. The truth is more nuanced than the hype, and honestly, knowing that nuance feels more empowering than blind hope.
Learn more about Rose →Hericenones and erinacines — the two main bioactive compounds in Hericium erinaceus — have been shown in laboratory studies to stimulate the production of Nerve Growth Factor (NGF), a protein essential for the growth, maintenance, and survival of neurons. This is the biological mechanism that makes lion's mane genuinely interesting for brain health, not just marketing language. The catch is that most of this research is in cell cultures or rodent models, not in human brains — and what happens in a petri dish doesn't always translate to a capsule you swallow.
The cognitive symptoms women experience in perimenopause and menopause — word retrieval problems, poor concentration, working memory lapses — are strongly linked to declining estrogen, which plays a direct role in neuronal signalling, brain glucose metabolism, and the cholinergic system. Lion's mane does not address estrogen deficiency, which means it is working on a different mechanism than the actual driver of menopausal cognitive change. Understanding this distinction matters enormously when evaluating whether a supplement is likely to help.
The landmark 2009 Mori et al. double-blind RCT that lion's mane proponents frequently cite enrolled 30 Japanese adults aged 50–80 with mild cognitive impairment, and found significant cognitive improvements compared to placebo over 16 weeks. This is a real, well-conducted study — but it involved a population with established cognitive decline, not healthy women in their 40s and 50s experiencing hormone-driven brain fog. Extrapolating those results to perimenopause without direct evidence is a significant stretch.
A 2010 Japanese study published in Biomedical Research found that women who consumed lion's mane cookies for four weeks reported lower scores on scales measuring anxiety, irritability, and depressive feelings compared to placebo — a result that has relevance given how mood disruption overlaps with cognitive symptoms in perimenopause. However, the sample was only 30 women, the intervention was short, and the outcome measures were self-reported mood scales rather than objective cognitive tests. It is promising but nowhere near conclusive.
A consistent limitation across the lion's mane human research base is that trials typically involve fewer than 50 participants and run for four to sixteen weeks — far too small and brief to draw firm conclusions about long-term cognitive benefit or safety in a specific population like perimenopausal women. This is not evidence that the supplement does not work; it is evidence that science has not yet done the work required to know. The gap between 'not disproven' and 'proven effective' is exactly where wellness marketing tends to operate.
Neuroinflammation is an emerging area of interest in menopause research, with some evidence suggesting that the hormonal transition may increase inflammatory signalling in the brain and contribute to cognitive symptoms. Lion's mane has demonstrated anti-inflammatory and antioxidant activity in animal and cell studies, which gives it a biologically plausible secondary pathway to support brain health beyond NGF stimulation. Whether this translates meaningfully to humans — and at what dose — remains an open question.
The doses used in clinical studies have ranged from 500mg to 3,000mg per day of whole mushroom or extract, and there is no established therapeutic dose for cognitive symptoms in menopausal women. Supplement products vary enormously in their concentration of active hericenones and erinacines, and in most countries they are not subject to the same regulatory scrutiny as pharmaceutical drugs. This means two products labelled identically may deliver very different amounts of the compounds that matter.
Available evidence and traditional use suggest lion's mane has a favourable safety profile for most people, with no serious adverse effects documented in clinical trials to date. However, case reports exist of allergic respiratory reactions and contact dermatitis, and people with mushroom allergies should approach it with caution. Long-term safety data in humans — particularly across the hormonal fluctuations of perimenopause — simply does not yet exist.
For women experiencing cognitive symptoms in perimenopause and menopause, the interventions with the strongest evidence base remain hormone therapy (particularly when started close to menopause onset), consistent aerobic exercise, and addressing sleep disruption — all of which directly target the hormonal and physiological mechanisms driving the fog. Lion's mane may eventually earn a more confident place in the toolkit, but currently sits in the 'possibly helpful, not yet proven for this use' category. Using it as a reason to avoid or delay more evidence-backed conversations with a doctor would not be in anyone's interest.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.